Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

eprosartan-hydroCHLOROthiazide

eprosartan-hydroCHLOROthiazide
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Teveten HCT TABLET, ORAL 600 mg-12.5 mg, 600 mg-25 mg    


Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

eprosartan-hydroCHLOROthiazide (Teveten HCT)

  • 600 mg-12.5 mg tablet oral Daily
  • 600 mg-25 mg tablet oral Daily

losartan-hydroCHLOROthiazide (Hyzaar)


Reviewed: April 27, 2010.


Last updated: Dec. 20, 2017







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.